Adenovirus comprising deletions on the E1A, E1B and E3 regions f

Details Adenovirus comprising deletions on the E1A, E1B and E3 regions f Adenovirus comprising deletions on the E1A, E1B and E3 regions f

1993-12-13

2000-01-11

Crouch, Deborah

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514851, 4353201, A61K 4800, C12N 1500

Patent

active

060136383

ABSTRACT:
The present invention relates, in general, to a adenovirus mediated transfer of genes to the lung. In particular, the present invention relates to a method of recombinant, replication-deficient adenovirus mediated transfer of desired genes to the lung whereby desired proteins of interest are produced for local and/or systemic use.

REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 4980286 (1990-12-01), Morgan et al.
Karlsson et al., "Stable Gene Transfer and Tissue-Specific Expression of a Human Globin Gene Using Adenoviral Vectors," EMBO J., 5, 2377 (1986).
Haj-Ahmad et al., "Development of a Helper-Independent Human Adenovirus Vector and its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene," J. Virol., 57, 267 (1986).
Levrero et al., "Hepatitis B Virus (HBV) X Gene Expression In Human Cells and Anti-X Antibodies Detection in Chronic HBV Infection," Hepadna Viruses, 237-252 (1987).
Levrero et al., "Defective and Nondefective Adenovirus Vectors for Expressing Foreign Genes in vitro and in vivo," Science, 101, 195-202 (1991).
Mansour et al., "Downstream Sequences Affect Transcription Initiation from the Adenovirus Major Late Promoter," Molecular and Cellular Biology, 6, 2684-2694 (Jul. 1986).
Riordan et al., "Identification of the Cyctic Fibrosis Gene: Cloning and Characterization of Complementary DNA," Science, 245, 1066-1072 (Sep. 1989).
Rommens et al., "Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping," Science, 245, 1059-1065 (Sep. 1989).
Rosenfeld et al., "In vivo Transfer of the Human Cystic Fibrosis Gene to the Respiratory Epithelium," Clinical Research, 39(2), 311A (1991).
Stratford-Perricaudet et al., "Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus Vector," Human Gene Therapy, 1, 241-256 (1990).
Ballay et al., "In vitro and in vivo Synthesis of the Hepatitis B Virus Surface Antigen and of the Receptor for Polymerized Human Serum Albumin from Recombinant Human Adenoviruses," The EMBO J., 4, 3861-3865 (1985).
Ballay et al., "Hepatitis B Adenovirus Recombinants as a Potential Live Vaccine," Hepadna Viruses, 481-493 (1987).
Chasse et al., "Human Recombinant Adenovirus Used to Correct a Mouse Enzyme Deficiency," Abstract of Paper Presented at Meeting on Regulation of Liver Gene Expression, May 3-May 7 (1989).
Chasse et al., "L'adenovirus: vecteur de therapie genique?" M/S Synthese, 5, 331-337 (1989).
Crystal et al., "New Viral Transfer System," Pediatric Pulmonology, 103 (Supplement 5), 103 (1990).
Crystal, R.G., ".alpha.1-Antitrypsin Deficiency, Emphysema, and Liver Disease," The Journal of Clinical Investigation, Inc., 85, 1343-1352 (May 1990).
Gilardi et al., "Expression of Human .alpha..sub.1 -antitrypsin Using a Recombinant Adenovirus Vector," FEBS Letters, 267(1), 60-62 (Jul. 1990).
Ginsberg et al., "Role of Early Region 3 (E3) in Pathogenesis of Adenovirus Disease," Proc. Natl. Acad. Sci. USA, 86, 3823-3827 (May 1989).
Jaffe et al., "Adenoviral Mediated Transfer and Expression of a Normal Human .alpha.1-Antitrypsin cDNA in Primary Rat Hepatocytes," Clinical Research, 39(2), 302A (1991).
Jones et al., "Isolation of Adenovirus Type 5 Host Range Deletion Mutants Defective for Transformation of Rat Embryo Cells," Cell, 17 683-689 (Jul. 1979).
Kerem et al., "Identification of Mutations in Regions Corresponding to the Two Putative Nucleotide (ATP)-Binding Folds of the Cystic Fibrosis Gene," Proc. Natl. Acad. Sci. USA, 87, 8447-8451 (Nov. 1990).
Kerem et al., "Identification of the Cystic Fibrosis Gene: Genetic Analysis," Science, 245, 1073-1080 (Sep. 1989).
Venkatesh et al, PNAS USA, vol. 87 (Nov. 1990) pp. 8746-8750.
Rosenfeld et al, Science, vol. 252 (Apr. 19, 1991) pp. 431-434.
Drumm et al, Cell, vol. 62 (Sep. 21, 1990) pp. 1227-1233.
Chasse, J. Cell. Biochem., Supp. 13B (Feb. 1989) p. 174.
Long et al (1984) Biochemistry 23, 4828-4837.
Riordan etal (1989) Science 245, 1066-1072.
Crystal et al (1994) Nature Genetics8, 42-51.
Gilardi etal (1990) FEBS Let 267, 60-62.
Rich etal (1990) Nature 347, 358-363.
Ballay etal (1987) Hepadna Viruses, Alan R. Liss, Inc, 481-483.
Blau etal (Nov. 2, 1995) New Eng. J. Med, 1204-1207.
Orkin etal (Dec. 7, 1995) Report and Recommendations . . . on Gene Therapy, 1-41; Office of NIH Publications.
Mulligan (1993) Science 260, 926-932.
Rosenfeld etal (1992) Cell 68, 142-154.
Hay et al (1995) Human Gene Therapy 6, 1487-1496.

Affiliated with

Also associated with

Rating

Adenovirus comprising deletions on the E1A, E1B and E3 regions f does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenovirus comprising deletions on the E1A, E1B and E3 regions f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus comprising deletions on the E1A, E1B and E3 regions f will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1462467